MUSTANG BIO, INC. Cash Equivalents, at Carrying Value
MUSTANG BIO, INC. (MBIO) had Cash Equivalents, at Carrying Value of $82.63 million as of 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2019-08-09
- 2019-06-30: Cash Equivalents, at Carrying Value $82.63M.
- 2019-03-31: Cash Equivalents, at Carrying Value $35.60M.
- 2018-12-31: Cash Equivalents, at Carrying Value $16.47M.
- 2018-09-30: Cash Equivalents, at Carrying Value $18.30M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2019-06-30 | $82.63M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $35.60M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $16.47M 10-Q · filed 2019-08-09 |
| 2018-09-30 | $18.30M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $11.74M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $17.75M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $34.98M 10-K · filed 2019-03-18 |
| 2017-09-30 | $33.21M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $53.79M 10-Q · filed 2017-08-14 |
| 2016-12-31 | $27.50M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |